$XE

X-Energy, Inc.

AlphAI earnings readSecond Quarter 2026 · AUG 13X-energy Reports Second Quarter 2026 ResultsVerdict: mixed

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

3
0
2

No SEC Form 4 filings for $XE in the last 30 days.

See all $XE insider activity →
Med

Needham initiates X-Energy stock with Hold rating on valuation

Needham initiated coverage on X-Energy (NASDAQ:XE) with a Hold rating, citing balanced risk and reward at current valuation. The stock trades at $10.60, down 63.7% over six months. X-Energy has 11.5 GW pipeline, $1.9B liquidity, and expects Q2 2027 permit for Dow project. Q2 loss was $0.15 per share, revenue rose 154% YoY to $54.6M. Piper Sandler cut price target to $8.00, maintains Underweight rating.

Cathie Wood Just Poured Millions Into 2 Nuclear Stocks -- and Neither Was NuScale Power

Cathie Wood's Ark Invest ETFs purchased shares of X-Energy (XE) and Oklo, investing approximately $5.1 million and $4.1 million respectively. X-Energy's shares were added to ARKK, ARKQ, and ARKX, while Oklo was added to ARKQ. Both companies are involved in nuclear energy, with X-Energy focusing on SMR design and nuclear fuel production, and Oklo developing nuclear fuel recycling and isotope production.

XE sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 5 news stories mentioning XE (X-Energy, Inc.). Coverage has skewed bullish: 3 bullish, 0 neutral, and 2 bearish.

Recent XE coverage spans financial news, market movers and earnings.

What's driving XE

AlphAI scores every news story that mentions XE with an AI model for sentiment and relevance, and aggregates insider trades from X-Energy, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $XE

Score
$XEMed

Needham initiates X-Energy stock with Hold rating on valuation

Needham initiated coverage on X-Energy (NASDAQ:XE) with a Hold rating, citing balanced risk and reward at current valuation. The stock trades at $10.60, down 63.7% over six months. X-Energy has 11.5 GW pipeline, $1.9B liquidity, and expects Q2 2027 permit for Dow project. Q2 loss was $0.15 per share, revenue rose 154% YoY to $54.6M. Piper Sandler cut price target to $8.00, maintains Underweight rating.

Cathie Wood Just Poured Millions Into 2 Nuclear Stocks -- and Neither Was NuScale Power

Cathie Wood's Ark Invest ETFs purchased shares of X-Energy (XE) and Oklo, investing approximately $5.1 million and $4.1 million respectively. X-Energy's shares were added to ARKK, ARKQ, and ARKX, while Oklo was added to ARKQ. Both companies are involved in nuclear energy, with X-Energy focusing on SMR design and nuclear fuel production, and Oklo developing nuclear fuel recycling and isotope production.

$BEMed

Why Are BE, OKLO, SMR, XE, NNE Stocks Rising Overnight?

Bloom Energy (BE) and nuclear power companies Oklo (OKLO), NuScale (SMR), X-Energy (XE), and Nano Nuclear (NNE) saw stock rises overnight after Elon Musk highlighted power infrastructure as a key constraint for AI growth. BE surged 6% in extended trading, while others gained 1-2%. Musk's SpaceX reported strong Q3 earnings, with AI-related revenue at $7.56 billion. Analysts and investors linked Musk's comments to increased demand for energy solutions.

$XEMed

Piper Sandler cuts X-Energy stock price target on fuel facility timing

Piper Sandler reduced its price target for X-Energy (NASDAQ:XE) to $8.00 from $9.00, citing mark-to-market adjustments and regulatory concerns. The stock is near its 52-week low, down 21% in the past week. X-Energy reported a Q2 loss of $0.15 per share but saw a 154% revenue increase, driven by engineering work. The company has $1.9 billion in cash and investments, with plans for commercial operations in 2028.

$XEMed

X-Energy, Inc. (XE) Signs JDA for 960 MW SMR Project in Indiana

X-Energy, Inc. (XE) signed a Joint Development Agreement with AEP and Amazon to evaluate a 960 MW, 12-unit Xe-100 SMR project in Indiana. Amazon will provide development capital. The project aims to bring clean, reliable power to the grid and is part of a collaboration targeting at least 5 GW of new nuclear capacity by 2039.

$MCKLow

Jim Cramer: This Health Care Stock Is A ‘Winner’, X-Energy Is ‘Losing Too Much Money’ - McKesson (NYSE:MC

Jim Cramer called McKesson (NYSE:MCK) a 'winner' and expects it to rise further. Leerink Partners raised its price target to $1,070. Cramer criticized X-Energy (NASDAQ:XE) for losing money, while Morgan Stanley lowered its target to $34. He advised waiting for Vishay Precision (NYSE:VPG) to drop 10% before buying. Medtronic (NYSE:MDT) was favored over MiniMed (NASDAQ:MMED), with BTIG lowering its target to $99. Cramer also discouraged investing in Cipher (NASDAQ:CIFR) due to losses.

Related tickers